FDA Studying Effects Of Radio-Frequency ID Technology On Liquid Drugs
This article was originally published in The Pink Sheet Daily
Executive Summary
The agency has seen "tremendous progress" in the move toward electronic product codes and use of radio-frequency identification, FDA says in its annual counterfeit drug update. FDA initiated 58 counterfeit drug investigations in 2004, up from 30 the previous year.
You may also be interested in...
FDA Anticounterfeiting Technology Guide Aims To Speed Industry Adoption
Agency will exercise enforcement discretion on labeling and GMP regulations that are triggered by radio frequency identification technology. FDA is working with EPC Global to establish standards of electronic pedigree.
Drug Radio Frequency ID To Be Widespread By 2007, FDA's McClellan Says
FDA expects the anticounterfeit technology will be implemented over a phased-in timeline. Although the agency does not plan to require use, it will take an active role in facilitating adoption of RFID.
SEC Seeks Vaccine Manufacturer Input On Pediatric Stockpile Accounting
Securities & Exchange Commission regulations on revenue recognition are preventing childhood vaccine manufacturers from selling product to a government stockpile. Rep. Waxman declares support for a special exemption for vaccine makers.